Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Gastrointestinal Medicine
Volume 2016 (2016), Article ID 6392028, 4 pages
http://dx.doi.org/10.1155/2016/6392028
Case Report

Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge

Department of Gastroenterology, Setúbal Hospital Center, São Bernardo Hospital, Setúbal, Portugal

Received 8 July 2016; Accepted 18 September 2016

Academic Editor: Maria Teresa Bardella

Copyright © 2016 Cláudio Martins et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. F. Ludvigsson, D. A. Leffler, J. C. Bai et al., “The Oslo definitions for coeliac disease and related terms,” Gut, vol. 62, no. 1, pp. 43–52, 2012. View at Publisher · View at Google Scholar
  2. T. R. Ziegler, C. Fernández-Estívariz, L. H. Gu, M. W. Fried, and L. M. Leader, “Severe villus atrophy and chronic malabsorption induced by azathioprine,” Gastroenterology, vol. 124, no. 7, pp. 1950–1957, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. M. M. Boscá, R. Añón, E. Mayordomo et al., “Methotrexate induced sprue-like syndrome,” World Journal of Gastroenterology, vol. 14, no. 45, pp. 7009–7011, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. N. J. Hall, G. Rubin, and A. Charnock, “Systematic review: adherence to a gluten-free diet in adult patients with coeliac disease,” Alimentary Pharmacology and Therapeutics, vol. 30, no. 4, pp. 315–330, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. DeGaetani, C. A. Tennyson, B. Lebwohl et al., “Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma,” The American Journal of Gastroenterology, vol. 108, no. 5, pp. 647–653, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Rubio-Tapia, M. L. Herman, J. F. Ludvigsson et al., “Severe spruelike enteropathy associated with olmesartan,” Mayo Clinic Proceedings, vol. 87, no. 8, pp. 732–738, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Laniro, S. Bibbo, M. Montalto et al., “Systematic review: sprue-like enteropathy associated with olmesartan,” Alimentary Pharmacology & Therapeutics, vol. 40, no. 1, pp. 16–23, 2014. View at Google Scholar
  8. M. Abdelghany, L. Gonzalez III, J. Slater, and C. Begley, “Olmesartan associated sprue-like enteropathy and colon perforation,” Case Reports in Gastrointestinal Medicine, vol. 2014, Article ID 494098, 3 pages, 2014. View at Publisher · View at Google Scholar
  9. E. Y. Karen Choi and B. McKenn, “Olmesartan-associated enteropathy: a review of clinical and histologic findings,” Archives of Pathology & Laboratory Medicine, vol. 139, no. 10, pp. 1242–1247, 2015. View at Publisher · View at Google Scholar
  10. S. Scialom, G. Malamut, B. Meresse et al., “Gastrointestinal disorder associated with olmesartan mimics autoimmune enteropathy,” PLoS ONE, vol. 10, no. 6, article e0125024, 2015. View at Publisher · View at Google Scholar · View at Scopus